Cargando…
CXCR3 predicts the prognosis of endometrial adenocarcinoma
OBJECTIVES: Currently, endometrial adenocarcinoma lacks an effective prognostic indicator. This study was to develop and validate a gene biomarker and a nomogram to predict the survival of endometrial adenocarcinoma, explore potential mechanisms and select sensitive drugs. METHODS: 425 endometrial a...
Autores principales: | Dong, He, Sun, Mengzi, Li, Hua, Yue, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903462/ https://www.ncbi.nlm.nih.gov/pubmed/36750966 http://dx.doi.org/10.1186/s12920-023-01451-9 |
Ejemplares similares
-
Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
por: Wu, Huanwen, et al.
Publicado: (2015) -
Construction and validation of nomograms for predicting the prognosis of grade 3 endometrial endometrioid adenocarcinoma cancers: a SEER-based study
por: Liu, Xiaofei, et al.
Publicado: (2021) -
Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values
por: Hu, Lian-Tao, et al.
Publicado: (2022) -
Predicting prognosis of endometrioid endometrial adenocarcinoma on the basis of gene expression and clinical features using Random Forest
por: Yin, Fufen, et al.
Publicado: (2019) -
Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer
por: Zhao, Jingkun, et al.
Publicado: (2017)